1. Home
  2. BBNX vs ABL Comparison

BBNX vs ABL Comparison

Compare BBNX & ABL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBNX
  • ABL
  • Stock Information
  • Founded
  • BBNX 2015
  • ABL 2004
  • Country
  • BBNX United States
  • ABL United States
  • Employees
  • BBNX N/A
  • ABL N/A
  • Industry
  • BBNX Medical/Dental Instruments
  • ABL Investment Managers
  • Sector
  • BBNX Health Care
  • ABL Finance
  • Exchange
  • BBNX Nasdaq
  • ABL Nasdaq
  • Market Cap
  • BBNX 740.7M
  • ABL 602.4M
  • IPO Year
  • BBNX 2025
  • ABL N/A
  • Fundamental
  • Price
  • BBNX $17.05
  • ABL $6.56
  • Analyst Decision
  • BBNX Strong Buy
  • ABL Strong Buy
  • Analyst Count
  • BBNX 10
  • ABL 3
  • Target Price
  • BBNX $24.40
  • ABL $12.83
  • AVG Volume (30 Days)
  • BBNX 811.1K
  • ABL 653.9K
  • Earning Date
  • BBNX 07-29-2025
  • ABL 08-07-2025
  • Dividend Yield
  • BBNX N/A
  • ABL N/A
  • EPS Growth
  • BBNX N/A
  • ABL N/A
  • EPS
  • BBNX N/A
  • ABL N/A
  • Revenue
  • BBNX $69,830,000.00
  • ABL $161,724,466.00
  • Revenue This Year
  • BBNX $32.71
  • ABL $77.22
  • Revenue Next Year
  • BBNX $37.37
  • ABL $29.93
  • P/E Ratio
  • BBNX N/A
  • ABL N/A
  • Revenue Growth
  • BBNX 38911.17
  • ABL 69.56
  • 52 Week Low
  • BBNX $8.89
  • ABL $4.60
  • 52 Week High
  • BBNX $24.50
  • ABL $10.95
  • Technical
  • Relative Strength Index (RSI)
  • BBNX N/A
  • ABL 69.70
  • Support Level
  • BBNX N/A
  • ABL $6.23
  • Resistance Level
  • BBNX N/A
  • ABL $6.67
  • Average True Range (ATR)
  • BBNX 0.00
  • ABL 0.28
  • MACD
  • BBNX 0.00
  • ABL 0.08
  • Stochastic Oscillator
  • BBNX 0.00
  • ABL 87.60

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

About ABL Abacus Life Inc.

Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.

Share on Social Networks: